January 6, 2026

Vyvgart plus low-dose steroids is safer treatment for severe gMG: Study – Myasthenia Gravis News

December 28, 2025

Advancing Treatment Options for Pediatric Myasthenia Gravis: A Q&A With Jonathan Strober, MD – American Journal of Managed Care

December 20, 2025

Top 5 Myasthenia Gravis Content of 2025 – American Journal of Managed Care

December 20, 2025

FDA Approves Inebilizumab for Myasthenia Gravis, Phase 3 PREVAiLS Study Launched, Tolebrutinib Fails Phase 3 PERSEUS Study – NeurologyLive

December 18, 2025

ST-Segment Elevation Myocardial Infarction in a Patient With Myasthenia Gravis After Intravenous Immunoglobulin Infusion – JACC Journals